These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis. Bochner F; Graham GG; Polverino A; Imhoff DM; Tregenza RA; Rolan PE; Cleland LG Eur J Clin Pharmacol; 1987; 32(2):153-8. PubMed ID: 3582479 [TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of salicylates: a re-assessment. Levy G Br J Clin Pharmacol; 1980 Oct; 10 Suppl 2(Suppl 2):285S-290S. PubMed ID: 7437270 [TBL] [Abstract][Full Text] [Related]
5. Proceedings: Kinetics of salicylate metabolism. Gibson T; Zaphiropoulos G; Grove J; Widdop B; Berry D Ann Rheum Dis; 1974 Jul; 33(4):410-1. PubMed ID: 4278234 [No Abstract] [Full Text] [Related]
6. The metabolism of aspirin in man: a population study. Hutt AJ; Caldwell J; Smith RL Xenobiotica; 1986 Mar; 16(3):239-49. PubMed ID: 3705620 [TBL] [Abstract][Full Text] [Related]
7. Metabolism of salicylate during chronic aspirin therapy. Rumble RH; Brooks PM; Roberts MS Br J Clin Pharmacol; 1980 Jan; 9(1):41-5. PubMed ID: 7356892 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease. Roberts MS; Rumble RH; Wanwimolruk S; Thomas D; Brooks PM Eur J Clin Pharmacol; 1983; 25(2):253-61. PubMed ID: 6628510 [TBL] [Abstract][Full Text] [Related]
9. Availability of salicylate from salsalate and aspirin. Dromgoole SH; Cassell S; Furst DE; Paulus HE Clin Pharmacol Ther; 1983 Oct; 34(4):539-45. PubMed ID: 6617077 [TBL] [Abstract][Full Text] [Related]
10. Depletion of plasma glycine and effect of glycine by mouth on salicylate metabolism during aspirin overdose. Patel DK; Ogunbona A; Notarianni LJ; Bennett PN Hum Exp Toxicol; 1990 Nov; 9(6):389-95. PubMed ID: 2271231 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, metabolism and disposition of salicylate in protein-deficient rats. Yue TL; Varma DR Drug Metab Dispos; 1982; 10(2):147-52. PubMed ID: 6124400 [TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of aspirin. Levy G Pediatrics; 1978 Nov; 62(5 Pt 2 Suppl):867-72. PubMed ID: 724339 [TBL] [Abstract][Full Text] [Related]
13. Fetal acquisition and neonatal elimination of a large amount of salicylate. Study of a neonate whose mother regularly took therapeutic doses of aspirin during pregnancy. Garrettson LK; Procknal JA; Levy G Clin Pharmacol Ther; 1975 Jan; 17(1):98-103. PubMed ID: 235394 [TBL] [Abstract][Full Text] [Related]
15. Induction of salicyluric acid formation in rheumatoid arthritis patients treated with salicylates. Day RO; Shen DD; Azarnoff DL Clin Pharmacokinet; 1983; 8(3):263-71. PubMed ID: 6851371 [TBL] [Abstract][Full Text] [Related]
16. Comparative metabolism of high doses of aspirin in man and rat. Patel DK; Notarianni LJ; Bennett PN Xenobiotica; 1990 Aug; 20(8):847-54. PubMed ID: 2219967 [TBL] [Abstract][Full Text] [Related]
17. Correlation of plateau serum salicylate level with rate of salicylate metabolism. Gupta N; Sarkissian E; Paulus HE Clin Pharmacol Ther; 1975 Sep; 18(3):350-5. PubMed ID: 1100304 [TBL] [Abstract][Full Text] [Related]
18. The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites. Ho PC; Triggs EJ; Bourne DW; Heazlewood VJ Br J Clin Pharmacol; 1985 May; 19(5):675-84. PubMed ID: 4005105 [TBL] [Abstract][Full Text] [Related]
19. Salicylate pharmacokinetics in patients with rheumatoid arthritis. Owen SG; Roberts MS; Friesen WT; Francis HW Br J Clin Pharmacol; 1989 Oct; 28(4):449-61. PubMed ID: 2590603 [TBL] [Abstract][Full Text] [Related]
20. Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis. Graham GG; Champion GD; Day RO; Paull PD Clin Pharmacol Ther; 1977 Oct; 22(4):410-20. PubMed ID: 902454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]